Grant of awards pursuant to 2025 h share incentive scheme

This announcement is made by Shanghai HeartCare Medical Technology Corporation Limited (the “Company”, together with its subsidiaries, the “Group”) pursuant to Rule 17.06A, 17.06B and 17.06C of the Rules Governing the Listing of Securities (the “Listing Rules”) of The Stock Exchange of Hong Kong Limited (the “Stock Exchange”). The Board announces that on September 21, 2026, the Company made a gran